http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113106169-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71de0b426be6a23c375c5536cbe2ad60 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6858 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6858 |
| filingDate | 2020-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1566eb41c769d26bee960ccf79042d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b44e1d6a26c58edacc1252b08e853010 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8affd13eaf4046253d627999c2efde46 |
| publicationDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113106169-A |
| titleOfInvention | Primer system for detection of SARS-CoV-2 nucleic acid and use thereof |
| abstract | The invention discloses a primer system for detecting SARS-CoV-2 polymorphic sites. The products prepared based on the primer system can simultaneously detect two polymorphic sites of SARS-CoV-2. Using this product, the genotype of the SARS-CoV-2 gene polymorphism is detected, and the detection results, combined with other clinical indicators, can provide a reference for clinicians to rationally formulate clinical treatment plans and avoid adverse reactions. After the nucleic acid is extracted by the present invention, two polymorphic sites on two genes of SARS-CoV-2 can be detected simultaneously in one reaction system, which is lower in cost and simpler in operation than technologies such as sequencing and real-time fluorescence quantitative PCR. , the spectrum is concise, the mass range is wide, and the accuracy and sensitivity are improved. |
| priorityDate | 2020-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.